Celltrion Healthcare Co Ltd
KOSDAQ:091990
Celltrion Healthcare Co Ltd
KOSDAQ:091990
Price:
75 900
KRW
-5.6%
Market Cap:
12.5T
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Celltrion Healthcare Co Ltd
75900
-4500 (-5.6%)
| 52 Week Range |
69 500
80 400
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Celltrion Healthcare Co Ltd
Income Statement
Earnings Waterfall
Celltrion Healthcare Co Ltd
Celltrion Healthcare Co Ltd
|
Revenue
|
2.1T
KRW
|
|
Cost of Revenue
|
-1.4T
KRW
|
|
Gross Profit
|
620.7B
KRW
|
|
Operating Expenses
|
-425.9B
KRW
|
|
Operating Income
|
194.8B
KRW
|
|
Other Expenses
|
-58.9B
KRW
|
|
Net Income
|
136B
KRW
|
Income Statement
Celltrion Healthcare Co Ltd
Celltrion Healthcare Co Ltd
Currency: KRW
| Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||
| Revenue |
733 263
N/A
|
738 881
+1%
|
874 221
+18%
|
870 062
0%
|
920 922
+6%
|
942 461
+2%
|
896 788
-5%
|
940 214
+5%
|
713 487
-24%
|
805 635
+13%
|
906 649
+13%
|
976 014
+8%
|
1 100 878
+13%
|
1 237 267
+12%
|
1 372 784
+11%
|
1 554 164
+13%
|
1 627 597
+5%
|
1 626 987
0%
|
1 639 954
+1%
|
1 585 654
-3%
|
1 804 486
+14%
|
1 863 891
+3%
|
1 949 646
+5%
|
2 036 930
+4%
|
1 972 188
-3%
|
2 060 053
+4%
|
2 066 847
+0%
|
|
| Gross Profit | ||||||||||||||||||||||||||||
| Cost of Revenue |
(537 831)
|
(541 090)
|
(632 912)
|
(650 435)
|
(696 793)
|
(753 270)
|
(727 461)
|
(756 710)
|
(644 612)
|
(728 424)
|
(831 817)
|
(896 116)
|
(891 574)
|
(967 395)
|
(1 011 062)
|
(1 067 377)
|
(1 085 822)
|
(1 097 392)
|
(1 111 541)
|
(1 156 565)
|
(1 373 984)
|
(1 411 410)
|
(1 483 396)
|
(1 492 232)
|
(1 410 434)
|
(1 449 393)
|
(1 446 156)
|
|
| Gross Profit |
195 432
N/A
|
197 791
+1%
|
241 309
+22%
|
219 628
-9%
|
224 129
+2%
|
189 191
-16%
|
169 327
-10%
|
183 502
+8%
|
68 876
-62%
|
77 210
+12%
|
74 831
-3%
|
79 898
+7%
|
209 304
+162%
|
269 872
+29%
|
361 722
+34%
|
486 787
+35%
|
541 775
+11%
|
529 595
-2%
|
528 413
0%
|
429 088
-19%
|
430 502
+0%
|
452 482
+5%
|
466 250
+3%
|
544 698
+17%
|
561 754
+3%
|
610 660
+9%
|
620 691
+2%
|
|
| Operating Income | ||||||||||||||||||||||||||||
| Operating Expenses |
(40 130)
|
(44 000)
|
(49 222)
|
(57 296)
|
(70 477)
|
(74 369)
|
(84 848)
|
(90 516)
|
(94 075)
|
(101 474)
|
(105 073)
|
(108 862)
|
(126 511)
|
(140 655)
|
(154 920)
|
(173 613)
|
(179 663)
|
(191 793)
|
(201 289)
|
(207 648)
|
(231 065)
|
(260 019)
|
(275 865)
|
(303 823)
|
(332 867)
|
(375 849)
|
(425 876)
|
|
| Selling, General & Administrative |
(32 822)
|
(37 060)
|
(42 238)
|
(48 877)
|
(58 259)
|
(64 008)
|
(73 622)
|
(78 597)
|
(80 246)
|
(86 805)
|
(89 475)
|
(92 799)
|
(107 768)
|
(118 383)
|
(127 857)
|
(142 668)
|
(146 992)
|
(155 485)
|
(166 219)
|
(173 511)
|
(196 761)
|
(209 741)
|
(231 188)
|
(264 599)
|
(309 809)
|
(352 643)
|
(393 478)
|
|
| Research & Development |
(7 130)
|
(6 785)
|
(6 845)
|
(8 277)
|
(12 036)
|
0
|
(11 019)
|
(11 674)
|
(13 505)
|
(13 953)
|
(14 479)
|
(14 486)
|
(16 684)
|
(20 011)
|
(24 626)
|
(28 353)
|
(29 733)
|
(33 177)
|
(31 618)
|
(29 755)
|
(29 227)
|
(24 427)
|
(18 708)
|
(13 518)
|
(17 750)
|
(17 367)
|
(25 918)
|
|
| Depreciation & Amortization |
(178)
|
(156)
|
(140)
|
(143)
|
(182)
|
0
|
(206)
|
(243)
|
(324)
|
(714)
|
(1 118)
|
(1 577)
|
(2 059)
|
(2 261)
|
(2 437)
|
(2 592)
|
(2 938)
|
(3 131)
|
(3 452)
|
(4 382)
|
(5 077)
|
(5 320)
|
(5 438)
|
(5 175)
|
(5 308)
|
(5 839)
|
(6 480)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
(10 361)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(20 531)
|
(20 531)
|
(20 531)
|
0
|
0
|
0
|
|
| Operating Income |
155 302
N/A
|
153 791
-1%
|
192 087
+25%
|
162 331
-15%
|
153 652
-5%
|
114 822
-25%
|
84 479
-26%
|
92 988
+10%
|
(25 200)
N/A
|
(24 263)
+4%
|
(30 241)
-25%
|
(28 964)
+4%
|
82 793
N/A
|
129 217
+56%
|
206 802
+60%
|
313 174
+51%
|
362 112
+16%
|
337 801
-7%
|
327 123
-3%
|
221 439
-32%
|
199 437
-10%
|
192 462
-3%
|
190 385
-1%
|
240 875
+27%
|
228 887
-5%
|
234 811
+3%
|
194 815
-17%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||
| Interest Income Expense |
(18 267)
|
(15 342)
|
50 109
|
40 967
|
15 195
|
132 202
|
84 694
|
74 762
|
49 520
|
(10 825)
|
(23 451)
|
(12 402)
|
(6 966)
|
32 334
|
20 931
|
12 432
|
(47 973)
|
(86 959)
|
(57 147)
|
(19 749)
|
18 634
|
36 631
|
44 450
|
126 637
|
7 887
|
55 777
|
35 023
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(360)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(20 531)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
(1)
|
0
|
0
|
0
|
30
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(3)
|
0
|
3
|
0
|
7
|
0
|
0
|
4
|
2
|
(43)
|
(103)
|
(92)
|
(174)
|
(126)
|
(91)
|
|
| Total Other Income |
1 717
|
(4 734)
|
(9 689)
|
(9 489)
|
37 265
|
3 145
|
1 773
|
447
|
90
|
(14 398)
|
6 232
|
11 218
|
(101)
|
3 388
|
(12 114)
|
(15 767)
|
534
|
669
|
694
|
851
|
714
|
(4 486)
|
(2 784)
|
(2 798)
|
(7 027)
|
(2 156)
|
(4 595)
|
|
| Pre-Tax Income |
138 751
N/A
|
133 714
-4%
|
232 505
+74%
|
193 808
-17%
|
206 136
+6%
|
250 168
+21%
|
170 946
-32%
|
168 197
-2%
|
24 409
-85%
|
(49 485)
N/A
|
(47 459)
+4%
|
(30 147)
+36%
|
75 362
N/A
|
164 939
+119%
|
215 621
+31%
|
309 841
+44%
|
314 680
+2%
|
251 511
-20%
|
270 669
+8%
|
202 545
-25%
|
198 257
-2%
|
224 564
+13%
|
231 947
+3%
|
364 622
+57%
|
229 573
-37%
|
288 306
+26%
|
225 153
-22%
|
|
| Net Income | ||||||||||||||||||||||||||||
| Tax Provision |
(41 585)
|
(43 258)
|
(68 526)
|
(60 786)
|
(48 698)
|
(58 574)
|
(39 300)
|
(39 342)
|
(13 023)
|
6 207
|
1 677
|
(11 876)
|
(10 400)
|
(29 624)
|
(42 358)
|
(60 625)
|
(74 273)
|
(55 789)
|
(57 660)
|
(35 022)
|
(45 690)
|
(59 920)
|
(91 900)
|
(127 555)
|
(82 394)
|
(130 663)
|
(89 202)
|
|
| Income from Continuing Operations |
97 166
|
90 457
|
163 981
|
133 023
|
157 439
|
191 594
|
131 646
|
128 855
|
11 386
|
(43 278)
|
(45 782)
|
(42 023)
|
64 962
|
135 315
|
173 263
|
249 217
|
240 407
|
195 723
|
213 010
|
167 523
|
152 567
|
164 645
|
140 048
|
237 067
|
147 179
|
157 644
|
135 951
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Net Income (Common) |
97 166
N/A
|
90 457
-7%
|
163 981
+81%
|
133 023
-19%
|
157 439
+18%
|
191 594
+22%
|
131 646
-31%
|
128 855
-2%
|
11 386
-91%
|
(43 278)
N/A
|
(45 782)
-6%
|
(42 023)
+8%
|
64 962
N/A
|
135 315
+108%
|
173 263
+28%
|
249 217
+44%
|
240 407
-4%
|
195 724
-19%
|
213 011
+9%
|
167 524
-21%
|
152 567
-9%
|
164 644
+8%
|
140 048
-15%
|
237 067
+69%
|
147 178
-38%
|
157 644
+7%
|
135 951
-14%
|
|
| EPS (Diluted) |
771.15
N/A
|
723.65
-6%
|
1 232.93
+70%
|
886.82
-28%
|
1 100.97
+24%
|
1 236.09
+12%
|
849.32
-31%
|
831.32
-2%
|
74.41
-91%
|
-284.72
N/A
|
-297.28
-4%
|
-274.66
+8%
|
444.94
N/A
|
896.12
+101%
|
1 125.08
+26%
|
1 618.29
+44%
|
1 592.09
-2%
|
1 254.64
-21%
|
1 356.99
+8%
|
1 026.34
-24%
|
953.36
-7%
|
1 019.83
+7%
|
868.01
-15%
|
1 468.51
+69%
|
949.23
-35%
|
981.61
+3%
|
846.74
-14%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
